News Focus
News Focus
icon url

manibiotech

07/30/24 7:03 PM

#709364 RE: meirluc #709359

Completely agree
We need some large non dilutive cash commitment from a big player .
icon url

iclight

07/30/24 8:42 PM

#709372 RE: meirluc #709359

It won’t replace SOC as it was never tested as a monotherapy.
Moot point as it doesn’t work anyway with or without chemorad.

Nobody is suffocating the company. LPs goal has nothing to do with cancer patients and everything to do with building and selling Advent.
icon url

skitahoe

07/30/24 9:02 PM

#709376 RE: meirluc #709359

Meirluc,

I believe that much depends on how the news is handled. If these events occur and no one in the investment public knows about it, you could be right. I don't believe that will happen, but anything is possible. I believe the news of approval will get substantial notice and once the price takes off, the MM's won't be able to hold it down. I do also believe the company has other news to release once we have an approval and that will keep the share price moving up.

Companies with approved potentially blockbuster drugs don't have market caps below a billion, not when at least a few billion are justified. I just don't believe the MM's, bashers, AdamF, etc. can keep this down once an approval is out. As for the court case, it's the frosting on the cake, but approval is the key to success and it will get us there. If there is any equity partnership, it will be under terms the LP agrees with, and I don't see that happening at below double digit share prices, but of course I could be wrong about that.

Gary
Bullish
Bullish